Alfons Biarnes Suñe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alfons Biarnes Suñe has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Ahmad Safiya
Catalan Institute of Pharmacology Foundation, Vall d'Hebron University Hospital, Barcelona, Spain
1 shared publicationAlessandra Verónica Binagui Buitureira
Servicio de Anestesiología y Reanimación, Fundació Hospital de l'Esperit Sant, Santa Coloma de Gramenet, España
1 shared publicationAna Faura
Servicio de Anestesiología y Reanimación, Hospital de Viladecans, Barcelona, España
1 shared publicationAna Pedregosa Sanz
Servicio de Anestesiología y Reanimación, Hospital d'Igualada, Barcelona, España
1 shared publication- Ana Tejedor
Department of Anesthesiology, Hospital Sant Joan Despí Moisès Broggi, Barcelona, Spain
1 shared publication Angels Camps
Anaesthesia and Resuscitation Service, Vall d'Hebron University Hospital, Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 1 June 2022
- Published by Elsevier in Cirugía Española
- Vol. 100 (6) , 352-358
Prevalencia preoperatoria de portadores asintomáticos de COVID-19 en hospitales de Cataluña durante la primera ola tras el reinicio de la actividad quirúrgica
- 1 June 2022
- Published by Elsevier in Cirugía Española
- Vol. 100 (6) , 352-358
Open AccessPrevalencia preoperatoria de portadores asintomáticos de COVID-19 en hospitales de Cataluña durante la primera ola tras el reinicio de la actividad quirúrgica
- 21 October 2020
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 68 (2) , 65-72
Impacto de la pandemia COVID-19 en la mortalidad del paciente anciano con fractura de cadera
- 21 October 2020
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 68 (2) , 65-72
Impacto de la pandemia COVID-19 en la mortalidad del paciente anciano con fractura de cadera
- 25 April 2019
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 66 (7) , 394-404
Damage Control Resuscitation en el paciente traumático
- 25 April 2019
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 66 (7) , 394-404
Damage Control Resuscitation en el paciente traumático
- 1 August 2018
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 43 (6) , 652-653
Regarding “Comparison of Continuous Proximal Versus Distal Adductor Canal Blocks for Total Knee Arthroplasty
- 1 August 2018
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 43 (6) , 652-653
Regarding “Comparison of Continuous Proximal Versus Distal Adductor Canal Blocks for Total Knee Arthroplasty
- 25 May 2016
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 119 (5) , 476-484
Impact of Implementing a Protocol on the Perioperative Management in Patients Treated with Antithrombotics Admitted for Hip Fracture Surgery: an Observational Study
This study aimed to describe the impact of implementing a protocol on the perioperative management of patients admitted for hip fracture treated with antithrombotics. A protocol was designed based on the recommendations from the American College of Chest Physicians (ACCP). After its implementation (May 2012), information on antithrombotic management was collected from admission to 3 months after surgery in retrospective (October 2011‐March 2012) and prospective (October 2012‐March 2013) cohorts. Patients' thromboembolic risk was classified into high, moderate or low according to the ACCP categories. A total of 113 and 101 cases were included in the retrospective and prospective cohorts, respectively. No differences in age, gender, American Society of Anaesthesiology score or thrombotic risk categories were observed between cohorts. Most patients were treated with aspirin or triflusal (55.1% and 48.1% in each cohort, respectively), clopidogrel (24.5% and 26.6%) or acenocoumarol (16.3% and 20.2%). In moderate to high thromboembolic risk patients, a higher rate of bridging therapy with full doses of enoxaparin (18.5% and 50%, p = 0.04 before and 9.1% and 43.7%, p = 0.02 after surgery) and a lower rate of aspirin discontinuation (76% and 55.3%, p = 0.03) were observed in the prospective cohort. Both cohorts had a similar percentage of cases with bleeding (68.1% and 68.3%) and thrombotic events (11.5% and 13%). No differences in the timing between surgery and the discontinuation or resumption of antithrombotics were noted. After the protocol implementation, aspirin was less often stopped and bridging therapy with therapeutic doses of enoxaparin was used more often. However, interruption and resumption times of antithrombotics remained almost unchanged. In order to achieve these goals, more efforts should be made to implement the protocol in clinical practice.
- 25 May 2016
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 119 (5) , 476-484
Impact of Implementing a Protocol on the Perioperative Management in Patients Treated with Antithrombotics Admitted for Hip Fracture Surgery: an Observational Study
This study aimed to describe the impact of implementing a protocol on the perioperative management of patients admitted for hip fracture treated with antithrombotics. A protocol was designed based on the recommendations from the American College of Chest Physicians (ACCP). After its implementation (May 2012), information on antithrombotic management was collected from admission to 3 months after surgery in retrospective (October 2011‐March 2012) and prospective (October 2012‐March 2013) cohorts. Patients' thromboembolic risk was classified into high, moderate or low according to the ACCP categories. A total of 113 and 101 cases were included in the retrospective and prospective cohorts, respectively. No differences in age, gender, American Society of Anaesthesiology score or thrombotic risk categories were observed between cohorts. Most patients were treated with aspirin or triflusal (55.1% and 48.1% in each cohort, respectively), clopidogrel (24.5% and 26.6%) or acenocoumarol (16.3% and 20.2%). In moderate to high thromboembolic risk patients, a higher rate of bridging therapy with full doses of enoxaparin (18.5% and 50%, p = 0.04 before and 9.1% and 43.7%, p = 0.02 after surgery) and a lower rate of aspirin discontinuation (76% and 55.3%, p = 0.03) were observed in the prospective cohort. Both cohorts had a similar percentage of cases with bleeding (68.1% and 68.3%) and thrombotic events (11.5% and 13%). No differences in the timing between surgery and the discontinuation or resumption of antithrombotics were noted. After the protocol implementation, aspirin was less often stopped and bridging therapy with therapeutic doses of enoxaparin was used more often. However, interruption and resumption times of antithrombotics remained almost unchanged. In order to achieve these goals, more efforts should be made to implement the protocol in clinical practice.
- 31 December 2012
- Published by Elsevier in Enfermería Clínica
- Vol. 22 (6) , 293-298
Náuseas y vómitos postoperatorios en cirugía mayor traumatológica
- 31 December 2012
- Published by Elsevier in Enfermería Clínica
- Vol. 22 (6) , 293-298
Náuseas y vómitos postoperatorios en cirugía mayor traumatológica
- 1 January 2006
- Vol. 53 (1) , 18-24
[Risk factors for transfusion in primary knee arthroplasty].
Transfusion is becoming safer but is not free of risk. It is important to establish a good approach to transfusion management and calculate real losses. Risk factors for transfusion should be identified. This was a prospective study of 102 patients who did not receive intraoperative autotransfusion of shed blood, selected from a group of 127 who were undergoing primary knee arthroplasty. We initially calculated the amount of blood shed. Then, by multivariate logistic regression analysis we identified the model that best predicted that a patient would require transfusion. Receiver operating characteristic curves were constructed and the area under the curves calculated. Mean (SD) blood loss was calculated to be 1786 (710) mL. The best model considered initial hemoglobin (Hb), weight, height, and sex as predictive factors: Probability = 1/ (1+e(-Z)), where Z = 11.542 - 1.074 x initial Hb (g/dL) - 0.039 x Weight (kg) + 0.031 x Height (cm) + 0.267 x (sex: male=1 or female=0). The area under the ROC curve was 0.805 (0.44). Initial Hb, which can be modified before surgery, is one of the factors that most affects whether or not the patient will need a transfusion. Therefore, one of our first objectives in the process of managing transfusion is to improve preoperative Hb values.
- 1 January 2006
- Vol. 53 (1) , 18-24
[Risk factors for transfusion in primary knee arthroplasty].
Transfusion is becoming safer but is not free of risk. It is important to establish a good approach to transfusion management and calculate real losses. Risk factors for transfusion should be identified. This was a prospective study of 102 patients who did not receive intraoperative autotransfusion of shed blood, selected from a group of 127 who were undergoing primary knee arthroplasty. We initially calculated the amount of blood shed. Then, by multivariate logistic regression analysis we identified the model that best predicted that a patient would require transfusion. Receiver operating characteristic curves were constructed and the area under the curves calculated. Mean (SD) blood loss was calculated to be 1786 (710) mL. The best model considered initial hemoglobin (Hb), weight, height, and sex as predictive factors: Probability = 1/ (1+e(-Z)), where Z = 11.542 - 1.074 x initial Hb (g/dL) - 0.039 x Weight (kg) + 0.031 x Height (cm) + 0.267 x (sex: male=1 or female=0). The area under the ROC curve was 0.805 (0.44). Initial Hb, which can be modified before surgery, is one of the factors that most affects whether or not the patient will need a transfusion. Therefore, one of our first objectives in the process of managing transfusion is to improve preoperative Hb values.
- Open Access
- 1 August 1996
- Published by Wiley in Anaesthesia
- Vol. 51 (8) , 797
Lambert‐Eaton (myasthenic) syndrome: pre‐anaesthetic treatment with intravenous immunoglobulins
- 1 August 1996
- Published by Wiley in Anaesthesia
- Vol. 51 (8) , 797
Open AccessLambert‐Eaton (myasthenic) syndrome: pre‐anaesthetic treatment with intravenous immunoglobulins